Human cells are composed of lipid bilayers as their primary structure. HighField takes advantage of this role of lipids in the body to treat a broad range of diseases.

Lipids self-assemble into fascinating structures, and we design these structures to target different cells in complex disease biology. 

Our cancer therapies attack cancer cells directly or modulate immune cells in the tumor microenvironment. Our lipid nanoparticles for gene therapy are nontoxic and provide for long-term therapeutic effect.